Lendlease under the Radar: Watch out for these trends for Constructi...

Summary Though the real estate sector was adversely impacted during the COVID-19 crisis with experts believing that the housing market might slip b...

Investing Today: 3 Drivers that move the needle for consumer discret...

Summary Consumer discretionary sector is among the industries that are hardest hit by the COVID 19, leading to further changes in the business mode...

Materials sector Stocks reflecting movements on ASX ledger: ABC, ORA...

Summary As per its latest update, ABC expects no material impact on revenue up until June next year (the time when lime supply contract is due to e...

‘D’ for Disruptive or Defensive: Dexus and Downer Stocks under Spotl...

Summary Investors find defensive stocks attractive as they offer dividend payments and generally generate steady income, irrespective of the market...

Is there a scope for these Logistics Companies to see a Comeback- TC...

Summary Rising COVID-19 cases in Victoria and NSW appears that the states have entered the second phase of COVID-19. The NSW-Victoria border would...

SEEK on the Charter: A Glance at Recent Developments

SEEK Limited (ASX:SEK) is an operator of the online employment classified and education and training. The Company witnessed an impressive stock perfor...

Mesoblast was the top gainer on the ASX today; Let’s find out why

COVID-19 turmoil is a public health crunch, with staggering fatalities and human suffering beyond words. This unprecedented crisis is being deeme...

ASX-listed Dental Stocks: Is there any relief coming in? PSQ, ONT, S...

Due to the rising number of coronavirus infections, many businesses were shut down amid COVID-19-induced restrictions. At the same time, some business...

ASX-listed Digital Healthcare Stock Amid COVID-19: A Look At RAP, HR...

The healthcare sector across the world is struggling with the myriad challenges thrown by the COVID-19 pandemic, and virtual healthcare is fast becomi...

ASX biotech companies creating a pandemic-free buzz!

As on 19 June 2020, the “pneumonia-like” illness has taken 456,432 lives with 8,538,928 confirmed cases recorded worldwide.  And with...

Are Investors Buying these Healthcare Stocks: Starpharma, Sigma and...

The healthcare sector is a significant and complex sector comprising a variety of companies engaged in manufacturing, developing, and selling of medic...

Don’t Miss! Small-Cap Healthcare Players’ Continued Focus on Innovat...

In the healthcare world, the general trend has been that smaller biotech players work on the innovation angle with research and development activities...

3 Small-cap Healthcare Stocks to Watch Out For – IMM, IDX, AT1

Small-cap stocks are listed companies with market capitalisation varying from USD 300 million to USD 2 billion or less. And in these stocks, there are...

Noxopharm Presented Highly Encouraging Veyonda® Clinical Data at ASC...

Summary Noxopharm presented two sets of clinical data concerning the development of Veyonda® as a treatment for end-stage prostate cancer at AS...

Prescient Reports March 2020 Quarterly Update; Cash Reserves at $8.2...

Australian based clinical-stage Oncology company Prescient Therapeutics Limited (ASX:PTX), recently reported operating highlights and financial outcom...

Lens over SUDA’s Operational Highlights in 1H FY20

Continuing its practice of delivering solid operational results, oro-mucosal drug delivery firm SUDA Pharmaceuticals Ltd (ASX:SUD) has recently declar...

Latest Brand Enhancements at Consumer Powerhouse-Pental Limited

A renowned ASX-listed consumer staples company producing some of the world’s most recognisable brands, Pental Limited (ASX:PTL) is a full end-to...

AuMake Ensures Contracts Will Be Met Despite Coronavirus Outbreak

The stock markets around the world have retreated with the fears prevailing around the fallout on global growth outlook due to China's coronavirus out...

Why is the THC Global share price rocketing higher?

Marijuana stocks or pot stocks are catching investors eyes these days after the legalisation of cannabis for medicinal and recreational use in many co...

A Smash Hit by Imugene: Received Core US Patent for HER-Vaxx

It’s surely a prosperous new year for the clinical-stage immuno-oncology player, Imugene Limited (ASX:IMU) that has received core US patent in t...